Santé Ventures, a healthcare and life sciences investment firm, announced today the appointment of Dennis McWilliams as Venture Partner based in Austin, Texas.
In his new role at Santé Ventures, McWilliams will grow the firm’s Entrepreneur Program by partnering with and mentoring entrepreneurs and creating new ventures for the fund.
As a serial entrepreneur, McWilliams has created numerous medical device and biopharmaceutical companies.
He is the founder of SparkMed Advisors, a boutique advisory focusing on bringing creative solutions to life science commercialization. Prior to that, McWilliams founded Apollo Endosurgery and served as CEO for 9 years until 2014, where he assumed the role of President and Chief Commercial Officer. Earlier in his career, he co-founded Chrysalis BioTechnology‚ a development stage biopharmaceutical company focused on developing novel drug therapies for tissue regeneration‚ including bone‚ cartilage‚ and dermal soft tissue.
McWilliams earned his M.S. in Engineering Management from Stanford University and his B.S. with honors from the University of Texas in Aerospace Engineering.
Founded in 2006, Santé Ventures is a specialized healthcare and life sciences investment firm with over a half-billion dollars in capital under management. The firm invests in early-stage companies developing innovative new medical technologies, biotechnologies and digitally-enabled healthcare services. Since inception, Santé has made 33 portfolio investments, including Claret Medical (Boston Scientific), TVA Medical (Becton Dickinson), Millipede Medical (Boston Scientific), Molecular Templates (MTEM), AbVitro (Celgene) and Explorys (IBM Corp).
The firm has additional offices in Houston.